The Use of mRNA for an HIV Envelope Vaccine (R41/R42)

Archived

National Institutes of Health

View on Grants.gov 📝 Build a proposal template ★ Save

Description

The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Technology Transfer (STTR) grant applications from Small Business Concerns (SBCs) and non-profit research institutions including academic partners that will focus on the development of novel direct mRNA-based and self-amplifying mRNA-based HIV envelope vaccine platforms suitable for use in clinical research. Such technologies should have commercial potential.

Who can apply

  • Small businesses

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedApr 19, 2016
  • ClosesApr 5, 2019
  • CFDA93.855, 93.856
Categories
Health

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro